Clonal chromosomal abnormalities in cutaneous T-cell lymphoma.

Area of Science:

• Oncology
• Genetics
• Immunology

Background:

• Cutaneous T-cell lymphoma (CTCL) is a heterogeneous group of malignant T-cell disorders.
• Accurate diagnosis and understanding of CTCL pathogenesis are crucial for effective treatment.
• Chromosomal abnormalities are frequently observed in hematologic malignancies, but their role in CTCL requires further elucidation.

Purpose of the Study:

• To investigate the frequency and nature of chromosomal abnormalities in patients with CTCL.
• To identify potential correlations between chromosomal changes and clinical parameters or disease characteristics.
• To explore the association of specific chromosomal rearrangements with CTCL development.

Main Methods:

• Chromosome analysis was performed on lymphocytes from blood, skin, and lymph nodes of 46 CTCL patients.
• Cultures were both stimulated and unstimulated to assess clonal chromosomal abnormalities.
• Patients' disease status and T-cell receptor gene involvement were evaluated.

Main Results:

• Clonal chromosomal abnormalities were detected in 8 of 46 (17.4%) CTCL patients.
• Nonclonal abnormalities were found in 9 additional patients.
• Unstimulated lymph node cultures yielded the highest proportion of clonal changes.
• Clonal changes were more prevalent in advanced disease and in patients positive for a specific monoclonal antibody.
• Rearrangements involving T-cell receptor gene loci on chromosomes #7 and #14 were uncommon.
• A potential association between CTCL and chromosome #10 rearrangements was suggested.

Conclusions:

• Chromosome analysis can identify clonal abnormalities in a subset of CTCL patients.
• Unstimulated lymph node cultures may be optimal for detecting these changes.
• The findings suggest a possible role for chromosome #10 rearrangements in CTCL pathogenesis, potentially linked to the interleukin-2 receptor gene.